Get the Stockscreener App
12.62
2.10%
-0.245
Schrodinger Inc stock is traded at $12.62, with a volume of 1.53M.
It is down -2.10% in the last 24 hours and up +9.38% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$12.87
Open:
$12.18
24h Volume:
1.53M
Relative Volume:
1.07
Market Cap:
$943.35M
Revenue:
$255.87M
Net Income/Loss:
$-103.27M
P/E Ratio:
-8.9482
EPS:
-1.4109
Net Cash Flow:
$12.46M
1W Performance:
+7.14%
1M Performance:
+9.38%
6M Performance:
-32.44%
1Y Performance:
-46.52%
1-Day Range:
$11.56
$12.79
1-Week Range:
$11.56
$13.25
52-Week Range:
$10.95
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
12.62 | 961.66M | 255.87M | -103.27M | 12.46M | -1.4109 |
VEEV
Veeva Systems Inc
|
169.62 | 27.94B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.67 | 9.98B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.38 | 9.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
83.14 | 6.98B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.57 | 4.76B | 637.78M | 239.40M | 307.21M | 1.1909 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
A Look At Schrödinger (NasdaqGS:SDGR) Valuation After Q1 Earnings And Hosted AI Software Push - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2026 Earnings Call Transcript - Insider Monkey
Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
Schrödinger Reports First Quarter 2026 Financial Results - BioSpace
Schrodinger Q1 Earnings Call Highlights - Yahoo Finance
TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Schrödinger outlines $218M-$228M 2026 ACV outlook with focus on hosted transition and Bunsen early access release - MSN
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates - MSN
Schrödinger Earnings Call: Growth Now, Profits Later - TipRanks
Schrödinger Inc (NASDAQ:SDGR) Q1 2026 Earnings: Revenue Beat Fails to Offset Loss Miss, Stock Slides - ChartMill
Schrödinger (SDGR) Q1 2026 Earnings Transcript - AOL.com
Schrödinger Q1 2026 slides: AI platform advances amid transition - Investing.com
Earnings call transcript: Schrödinger misses EPS but beats revenue in Q1 2026 - Investing.com
Earnings Flash (SDGR) Schrodinger, Inc. Reports Q1 Revenue $58.6M, vs. FactSet Est of $47.6M - marketscreener.com
Schrödinger tees up AI drug-discovery tool as Ajax sale hits $2.3B - Stock Titan
Schrödinger (NASDAQ: SDGR) Q1 2026 revenue, loss and cash position - Stock Titan
Schrödinger, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Schrödinger (NASDAQ: SDGR) posts Q1 2026 $58.6M revenue, keeps outlook - Stock Titan
Can Schrödinger’s (SDGR) AI-Hosted Push Recast Its Investment Story Beyond Drug Discovery Hype? - simplywall.st
MSN Money - MSN
Here’s What the Street Thinks About Schrödinger (SDGR) - Insider Monkey
Schrödinger to Participate in Upcoming Investor Conferences - PharmiWeb.com
Liquidity Mapping Around (SDGR) Price Events - Stock Traders Daily
Schrödinger will webcast two healthcare conference talks in May - Stock Titan
Insider sales reported for SDGR (NASDAQ: SDGR) including 752/775/608 shares - Stock Titan
SDGR Stock Price, Quote & Chart | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
3.19M-share disclosure by Schrodinger (NASDAQ: SDGR) shows a 4.9% stake - Stock Titan
Earnings Preview: Schrodinger to Report Financial Results Post-market on May 05 - Moomoo
Vanguard Portfolio Management (SDGR) holds 3.91M shares, 6.04% stake - Stock Titan
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance
Schrodinger (SDGR) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Schrödinger Appoints Geoffrey Porges as Chief Financial Officer - Quantisnow
Form DEFA14A Schrodinger, Inc. - StreetInsider
[ARS] Schrodinger, Inc. SEC Filing - Stock Titan
Schrödinger (NASDAQ: SDGR) seeks approval for 3M-share equity plan increase - Stock Titan
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Quantisnow
Schrödinger updates 2025 software growth guidance to 8%-13% amid pharma scale-up delays and operational efficiency focus - MSN
Schrodinger downgraded at Citi after clinical program exit - MSN
Why (SDGR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SDGR (Schrodinger Inc.) Q4 2025 EPS far outpaces consensus estimates, shares climb 2.32 percent.Fast Rising Picks - Xã Thanh Hà
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 T - GuruFocus
Schrodinger: AI Threat Is Looming Large (Rating Downgrade) - Seeking Alpha
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
SDGR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Schrödinger to Announce First Quarter 2026 Financial Results on May 5 - GuruFocus
Schrödinger’s impressive revenue growth justifies its high P/S ratio, fueling investor optimism and a bullish view on shares. A warning sign remains, signaling some risks persist despite positive outlooks. - Moomoo
Press Release: Schrödinger to Announce First Quarter 2026 Financial Results on May 5 - 富途牛牛
Schrödinger schedules May 5 earnings call, webcast at 4:30 p.m. ET - Stock Titan
Schrodinger Inc (SDGR) Stock Up 3.6% and Still Undervalued -- GF Score: 71/100 - GuruFocus
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farid Ramy | President & CEO |
Apr 17 '26 |
Option Exercise |
3.07 |
117,527 |
360,808 |
405,351 |
| Farid Ramy | President & CEO |
Apr 16 '26 |
Option Exercise |
3.07 |
43,000 |
132,010 |
373,824 |
| Farid Ramy | President & CEO |
Apr 16 '26 |
Sale |
12.33 |
43,000 |
530,233 |
330,824 |
| Farid Ramy | President & CEO |
Apr 17 '26 |
Sale |
12.21 |
43,000 |
524,944 |
330,824 |
| Jain Rachit | EVP & CFO |
Apr 16 '26 |
Sale |
12.75 |
844 |
10,758 |
51,752 |
2.18%
2.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):